Management of Cerebral Salt Wasting (CSW)
CSW should be treated with aggressive sodium and volume replacement using intravenous fluids, with fludrocortisone added for severe or refractory cases, while fluid restriction must be strictly avoided as it increases risk of cerebral infarction. 1
Treatment Algorithm Based on Symptom Severity
Severe Symptoms (Mental status changes, seizures, or SAH patients)
- Admit to ICU with continuous monitoring 1
- Hypertonic saline (3% NaCl) plus fludrocortisone for 7 days 1
- Correct 6 mmol/L over 6 hours OR until severe symptoms resolve
- Critical limit: Total sodium correction must not exceed 8 mmol/L in 24 hours (if 6 mmol/L corrected in first 6 hours, increase no more than 2 mmol/L in remaining 18 hours) 1
- Calculate sodium deficit: Desired increase in Na (mEq) × (0.5 × ideal body weight in kg) 1
- Monitor sodium every 2 hours, strict intake/output, daily weights 1
- If no response to hypertonic saline, add normal saline IVF 1
Mild Symptoms (Nausea/vomiting, headaches, Na <120 mmol/L)
- Transfer to intermediate care unit 1
- Normal saline infusion with sodium supplementation 1
- Monitor sodium every 4 hours 1
- Continue until sodium reaches 131 mmol/L 1
Asymptomatic or Mild Hyponatremia
- Oral salt tablets (NaCl 100 mEq three times daily) 1
- High protein diet 1
- Liberal fluid intake with normal saline 1
- Monitor daily sodium levels 1
Special Considerations for SAH Patients
SAH patients require treatment even when sodium is 131-135 mmol/L (not just <131 mmol/L) due to vasospasm risk 1. This is a critical distinction from other neurosurgical patients.
Fluid restriction is contraindicated in SAH patients with hyponatremia - retrospective data showed cerebral infarction developed in 21 of 26 (81%) fluid-restricted SAH patients versus 19 of 90 (21%) normonatremic patients 1.
Fludrocortisone Use
Fludrocortisone (Class I evidence in SAH patients) 1:
- Reduces negative sodium balance (63% vs 38% in controls, p=0.041) 1
- Dosing: 0.1 mg three times daily 1
- Reduces urinary sodium excretion and urine volume 1
- Monitor and correct hypokalemia (common side effect) 1
- Particularly useful in refractory cases requiring large volumes of hypertonic saline 2, 3
Alternative: Hydrocortisone 1200 mg/day for 10 days (Class I evidence) prevents excess sodium excretion and maintains target sodium levels in SAH patients 1
Rate of Correction Guidelines
- Do not exceed 10 mmol/L correction per day 1
- Rapid correction (>1 mmol/L/hour) reserved only for acute hyponatremia (<48 hours) with severe symptoms 1
- Chronic hyponatremia should NOT be rapidly corrected (risk of osmotic demyelination) 1
Critical Pitfall to Avoid
The most dangerous error is misdiagnosing CSW as SIADH and treating with fluid restriction. CSW is a hypovolemic state requiring aggressive volume replacement, while SIADH is euvolemic requiring fluid restriction. The key distinguishing feature is volume status assessment - CSW presents with clinical hypovolemia (orthostatic hypotension, decreased skin turgor, low CVP if monitored), elevated urine sodium (>40 mEq/L), and high urine output 1, 4, 5. Both conditions show low serum sodium and high urine osmolality, making volume status the critical differentiator 5.